SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that cannabis rescheduling may be imminent, with some anticipating a resulting sector-wide surge. The community is actively discussing the potential impact of a presidential executive order on tax relief and banking access. Some investors are optimistic about a short squeeze, while others remain cautious due to the company's history.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to positive reactions to its AI and autonomy day, with discussions focusing on the potential of its new in-house AI chip and self-driving capabilities. The community is weighing the company's advancements against competitors like Tesla and speculating on a possible short squeeze. Some investors are concerned about cash burn and the timeline for seeing returns on these new technologies.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to the upcoming launch of BlueBird 6, marking a significant step towards a launch cadence of approximately every 45 days in 2026; this represents a shift from concept to operational deployment. The community is buzzing about the potential for a Starlink competitor and the company's long-term prospects, with some highlighting the high short interest and potential for a squeeze.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending amidst reports that Trump may consider rescheduling marijuana, potentially affecting taxation and medical access. The community is discussing the potential impact of this policy change and whether it will be a "sell the news" event. Scanners continue to light up as cannabis tickers show increased interest in response to the news.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to its active community and ongoing initiatives, particularly the upcoming availability of Kendu Spice on Amazon. The community is actively discussing the project's strong IRL presence and the numerous businesses being built around the KENDU brand. Many see it as a long-term play with a dedicated and growing community.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as speculation mounts around potential federal cannabis policy changes, specifically regarding rescheduling. Community chatter revolves around whether an executive order will materialize, with some anticipating a significant sector-wide surge while others remain cautiously optimistic due to past disappointments. The ETF's exposure to US cannabis companies positions it to potentially benefit from any regulatory easing.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending due to analyst upgrades and positive sentiment around the launch of Attruby, with the community actively discussing its potential to outperform competitors and the impact of upcoming Phase 3 readouts. Community members are weighing its growth potential in the context of a potentially undervalued biotech, while also considering the potential for acquisition by a major pharmaceutical company. Actionable trade alerts highlight possible entry and exit points based on technical analysis.

Gunz

Gunz ($GUN) is trending amid community excitement about potential breakouts and large whale buys, with some eyeing a return to all-time highs. The token is also getting attention due to its association with the Off The Grid (OTG) web3 game on the Avalanche network ($AVAX), leading to discussions about its tokenomics and potential for quick gains.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending due to discussions around its potential role in powering AI data centers and a recent agreement with the Tennessee Valley Authority, though concerns persist around its financial performance and Fluor's stake monetization. The community is weighing the company's regulatory advantages and the increasing need for SMR technology against factors like potential share dilution and competition in the sector. Recent analyst target price reductions and overall nuclear sector bearishness may also be contributing to the conversation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as the community discusses its recent dip despite strong earnings and positive AI revenue forecasts, with some attributing the downturn to margin concerns and sector rotation. Despite the drop, analysts are maintaining positive outlooks, leading to speculation about a potential rebound. Bullish investors see the dip as a buying opportunity, citing Broadcom's significant role in AI and a substantial order backlog.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alpha Tau Medical (NASDAQ:DRTS) Given New $7.00 Price Target at Citigroup

Citigroup reduced their target price on shares of Alpha Tau Medical from $8.00 to $7.00 and set a "buy" rating for the company in a research note on Wednesday...

Why Did Alpha Tau Medical (DRTS) Shares Jump Over 25% In After-Hours Trading?

Alpha Tau Medical surged in after-hours trading after treating the first patient in its pilot study for recurrent glioblastoma with Alpha DaRT therapy.read more...

Alpha Tau Medical (NASDAQ:DRTS) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Alpha Tau Medical (NASDAQ:DRTS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.12) by...

Alpha Tau Medical Ltd. shares hit their highest level on Monday in three months following the company's report of a smaller-than-expected quarterly loss and advances in several U.S. FDA-approved clinical trials.The stock rose 11.1% to close at $3.10 and extended gains by another 6.5% to $3.30 in after-hours trading.For the first quarter ending March 31, the company posted a net loss of $8.7 million, equivalent to $0.12 per share,&nbsp;widening from a loss of $8.0 million or $0.11 per share&nbsp;a year earlier.According to The Fly, analysts expected Alpha Tau Medical to report a&nbsp;bigger loss of $0.13 per share.The company's financial income rose to $0.7 million from $0.4 million in the previous year due to reduced warrant remeasurement expenses,&nbsp;offsetting the decrease in interest income from deposits.Alpha Tau's regulatory achievements, including four active FDA Investigational Device Exemptions (IDEs) and upcoming U.S. trials for pancreatic cancer along with recurrent glioblastoma multiforme (GBM), generated positive investor response, which led to share price increases even though financial losses continued.CEO Uzi Sofer said that 2025 started with significant milestones,&nbsp;such as facility expansion in New Hampshire and strong clinical advancements,&nbsp;which received support from a $36.9 million capital increase.On Stocktwits, retail sentiment was ‘bearish’ amid ‘high’ message volume.The stock has remained flat so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Israel-based biopharma reported positive final results from a randomized Phase 2 study of its lead oncology drug, CM24, in patients with pancreatic ductal adenocarcinoma.

Alpha Tau Stock Rallies To 3-Month High On Smaller-Than-Feared Q1 Loss: Retail Sentiment Stays Bearish

The company’s stock surged to a three-month high following its Q1 report, progress in FDA-approved clinical trials, and a recent capital raise.

Equity

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

DRTS
ALPHA TAU MEDICAL LTD

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DRTS News

DRTSALPHA TAU MEDICAL LTD